181 related articles for article (PubMed ID: 11559218)
1. Tacrolimus ointment in the treatment of chronic cutaneous graft-vs-host disease: a case series of 18 patients.
Choi CJ; Nghiem P
Arch Dermatol; 2001 Sep; 137(9):1202-6. PubMed ID: 11559218
[TBL] [Abstract][Full Text] [Related]
2. Toxic tacrolimus levels after application of topical tacrolimus and use of occlusive dressings in two bone marrow transplant recipients with cutaneous graft-versus-host disease.
Olson KA; West K; McCarthy PL
Pharmacotherapy; 2014 Jun; 34(6):e60-4. PubMed ID: 24700567
[TBL] [Abstract][Full Text] [Related]
3. Topical tacrolimus--a novel treatment alternative for cutaneous chronic graft-versus-host disease.
Elad S; Or R; Resnick I; Shapira MY
Transpl Int; 2003 Sep; 16(9):665-70. PubMed ID: 12768230
[TBL] [Abstract][Full Text] [Related]
4. Long-term result of maintenance treatment with tacrolimus ointment in chronic ocular graft-versus-host disease.
Jung JW; Lee YJ; Yoon SC; Kim TI; Kim EK; Seo KY
Am J Ophthalmol; 2015 Mar; 159(3):519-27.e1. PubMed ID: 25498356
[TBL] [Abstract][Full Text] [Related]
5. Tacrolimus ointment: the treatment of atopic dermatitis and other inflammatory cutaneous disease.
Carroll CL; Fleischer AB
Expert Opin Pharmacother; 2004 Oct; 5(10):2127-37. PubMed ID: 15461548
[TBL] [Abstract][Full Text] [Related]
6. An approach to pruritus in atopic dermatitis: a critical systematic review of the tacrolimus ointment literature.
Fleischer AB; Boguniewicz M
J Drugs Dermatol; 2010 May; 9(5):488-98. PubMed ID: 20480792
[TBL] [Abstract][Full Text] [Related]
7. Tacrolimus ointment for the treatment of atopic dermatitis in adult patients: part II, safety.
Soter NA; Fleischer AB; Webster GF; Monroe E; Lawrence I
J Am Acad Dermatol; 2001 Jan; 44(1 Suppl):S39-46. PubMed ID: 11145794
[TBL] [Abstract][Full Text] [Related]
8. Successful treatment of oral lichen planus-like chronic graft-versus-host disease with topical tacrolimus: a case report.
Sánchez AR; Sheridan PJ; Rogers RS
J Periodontol; 2004 Apr; 75(4):613-9. PubMed ID: 15152828
[TBL] [Abstract][Full Text] [Related]
9. Efficacy and safety of tacrolimus ointment in pediatric Patients with moderate to severe atopic dermatitis.
Singalavanija S; Noppakun N; Limpongsanuruk W; Wisuthsarewong W; Aunhachoke K; Chunharas A; Wananukul S; Akaraphanth R
J Med Assoc Thai; 2006 Nov; 89(11):1915-22. PubMed ID: 17205874
[TBL] [Abstract][Full Text] [Related]
10. Oral graft vs. host disease in children--treatment with topical tacrolimus ointment.
Albert MH; Becker B; Schuster FR; Klein B; Binder V; Adam K; Nienhoff C; Führer M; Borkhardt A
Pediatr Transplant; 2007 May; 11(3):306-11. PubMed ID: 17430488
[TBL] [Abstract][Full Text] [Related]
11. A short-term trial of tacrolimus ointment for atopic dermatitis. European Tacrolimus Multicenter Atopic Dermatitis Study Group.
Ruzicka T; Bieber T; Schöpf E; Rubins A; Dobozy A; Bos JD; Jablonska S; Ahmed I; Thestrup-Pedersen K; Daniel F; Finzi A; Reitamo S
N Engl J Med; 1997 Sep; 337(12):816-21. PubMed ID: 9295241
[TBL] [Abstract][Full Text] [Related]
12. Tacrolimus ointment 0.03% is safe and effective for the treatment of mild to moderate atopic dermatitis in pediatric patients: results from a randomized, double-blind, vehicle-controlled study.
Schachner LA; Lamerson C; Sheehan MP; Boguniewicz M; Mosser J; Raimer S; Shull T; Jaracz E;
Pediatrics; 2005 Sep; 116(3):e334-42. PubMed ID: 16140675
[TBL] [Abstract][Full Text] [Related]
13. [Pharmacokinetics of tacrolimus following topical application of tacrolimus ointment in adult and paediatric patients with atopic dermatitis].
Undre NA
Actas Dermosifiliogr; 2008 Feb; 99 Suppl 2():2-7. PubMed ID: 18346423
[TBL] [Abstract][Full Text] [Related]
14. A multicentre, randomized, double-blind, controlled study of long-term treatment with 0.1% tacrolimus ointment in adults with moderate to severe atopic dermatitis.
Reitamo S; Ortonne JP; Sand C; Cambazard F; Bieber T; Fölster-Holst R; Vena G; Bos JD; Fabbri P; Groenhoej Larsen C;
Br J Dermatol; 2005 Jun; 152(6):1282-9. PubMed ID: 15948994
[TBL] [Abstract][Full Text] [Related]
15. Safe and effective treatment of refractory facial lesions in atopic dermatitis using topical tacrolimus following corticosteroid discontinuation.
Kawakami T; Soma Y; Morita E; Koro O; Yamamoto S; Nakamura K; Tamaki K; Yajima K; Imaizumi A; Matsunaga R; Murakami N; Kashima M; Mizoguchi M
Dermatology; 2001; 203(1):32-7. PubMed ID: 11549797
[TBL] [Abstract][Full Text] [Related]
16. Successful treatment using tacrolimus ointment for cutaneous graft-versus-host disease.
Kunitomi A; Iida H; Kamiya Y; Hayashi M; Sao H
Int J Hematol; 2008 Nov; 88(4):465-467. PubMed ID: 19002390
[No Abstract] [Full Text] [Related]
17. Superiority of tacrolimus 0.1% ointment compared with fluticasone 0.005% in adults with moderate to severe atopic dermatitis of the face: results from a randomized, double-blind trial.
Doss N; Reitamo S; Dubertret L; Fekete GL; Kamoun MR; Lahfa M; Ortonne JP
Br J Dermatol; 2009 Aug; 161(2):427-34. PubMed ID: 19416227
[TBL] [Abstract][Full Text] [Related]
18. Tacrolimus ointment. A review of its therapeutic potential as a topical therapy in atopic dermatitis.
Cheer SM; Plosker GL
Am J Clin Dermatol; 2001; 2(6):389-406. PubMed ID: 11770393
[TBL] [Abstract][Full Text] [Related]
19. [Tacrolimus ointment in the treatment of chronic cutaneous graft-versus-host disease].
Firmin D; Karam A; Guillerm G; Roguedas AM; Berthou C; Misery L
Ann Dermatol Venereol; 2008 Mar; 135(3):234-6. PubMed ID: 18374862
[No Abstract] [Full Text] [Related]
20. Efficacy of tacrolimus 0.03% ointment as second-line treatment for children with moderate-to-severe atopic dermatitis: evidence from a randomized, double-blind non-inferiority trial vs. fluticasone 0.005% ointment.
Doss N; Kamoun MR; Dubertret L; Cambazard F; Remitz A; Lahfa M; de Prost Y
Pediatr Allergy Immunol; 2010 Mar; 21(2 Pt 1):321-9. PubMed ID: 19563466
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
